• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NXSTAGE MEDICAL, INC. NXSTAGE SYSTEM ONE; HIGH PERMEABILITY HEMODIALYSIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NXSTAGE MEDICAL, INC. NXSTAGE SYSTEM ONE; HIGH PERMEABILITY HEMODIALYSIS SYSTEM Back to Search Results
Model Number CAR-172-C
Device Problem Fluid/Blood Leak (1250)
Patient Problems Hemorrhage/Bleeding (1888); Nausea (1970); Dizziness (2194)
Event Date 10/13/2021
Event Type  Injury  
Manufacturer Narrative
The involved cartridge was discarded and not available for evaluation.A device history record (dhr) review was conducted for the reported lot number and revealed the product was released for distribution having met quality and manufacturing specifications and requirements.Available log files were retrieved and analyzed which showed the cycler performed as designed and intended, and alarmed appropriately when alarm conditions were present.The nxstage system one user guide outlines risks associated with performing hemodialysis therapy and warns that treatment should only be performed by a trained and qualified person who must respond promptly to harmful conditions during treatment.
 
Event Description
A report was received on 14 oct 2021 regarding a (b)(6) year old male with a medical history including end stage renal disease and recent (nos) lower gastrointestinal bleed, who stated an unspecified amount of blood leaked during a home hemodialysis treatment on (b)(6) 2021.Additional information was received on 15 oct 2021 and 18 oct 2021 from the home therapy nurse (htn) who stated the care partner reported a ¿large amount¿ of dried blood was seen on the floor by the cycler.The patient felt nauseous, weak, and lightheaded.Emergency medical services (ems) were called who transported the patient to hospital where they were admitted on (b)(6) 2021.Per the htn, the patient¿s hemoglobin was 4.9g/dl and 6 units of packed red blood cells (prbc) were given.The patient stabilized and was discharged from the hospital on (b)(6) 2021 for re-training before resuming hemodialysis treatment with the nxstage device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NXSTAGE SYSTEM ONE
Type of Device
HIGH PERMEABILITY HEMODIALYSIS SYSTEM
Manufacturer (Section D)
NXSTAGE MEDICAL, INC.
350 merrimack street
lawrence MA 01843
Manufacturer (Section G)
MEDIMEXICO S. DE R. L. DE C. V
av. valle imperial no. 10523
parque industrial valle sur
tijuana 22180
MX   22180
Manufacturer Contact
paula rogalski
nxstage medical, inc.
350 merrimack street
lawrence, MA 01843
MDR Report Key12744711
MDR Text Key280053919
Report Number3003464075-2021-00064
Device Sequence Number1
Product Code KDI
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K140526
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 11/03/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/03/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date12/01/2022
Device Model NumberCAR-172-C
Device Catalogue NumberCAR-172-C
Device Lot Number10477031
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received10/14/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/27/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age63 YR
Patient Weight99
-
-